Fig. 1From: Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trialNumber of participants in the intervention arm and their exclusion criteria for this study. IVM ivermectin, DHP dihydroartemisinin-piperaquineBack to article page